Status:
WITHDRAWN
Allogeneic Umbilical Cord Blood Therapy for Chronic TBI
Lead Sponsor:
Bundang CHA Hospital
Conditions:
Traumatic Brain Injury
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This open label trial is conducted to investigate the efficacy and safety of umbilical cord blood therapy for chronic traumatic brain injury patients. The study hypothesis is that the participants wi...
Detailed Description
Traumatic brain injury patients have been increasing due to various accidents. After acute therapeutic intervention, rehabilitation is the conventional main treatment with medication. However, in chro...
Eligibility Criteria
Inclusion
- Chronic Traumatic Brain Injury Patient (onset duration: over 6 months)
- Glasgow Outcome Scale: 2, 3, 4, 5
Exclusion
- High risk of pneumonia or renal function deterioration after immunosuppressant
- Possibility of drug hypersensitivity which is related to this study remedy
- Intractable seizure disorder
- Poor cooperation of guardian,including inactive attitude for rehabilitation
Key Trial Info
Start Date :
July 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2015
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01451528
Start Date
July 1 2014
End Date
December 1 2015
Last Update
April 3 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHA Bundang Medical Center, CHA University
Seongnam-si, Gyeonggi-do, South Korea, 463-712